Trichosporonasahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing
Trichosporonasahii is the causative agent of both superficial and deep-seated infections of increasing morbidity and mortality. Urinary tract infections (UTIs) due to T. asahii, frequently associated with indwelling medical devices, have been reported over the years. However, few studies have specifically focused on the genotypic diversity of T. asahii isolates from urine specimens from intensive care units (ICUs), let alone potential virulence factors and antifungal susceptibility testing. In the present study, 23 T. asahii isolates were collected from UTI patients in ICUs between January 2008 and January 2012. Three genotypes (I, III, IV) were determined based on the combination of internal transcribed spacer and intergenic spacer locus PCR. Protease, phospholipase and haemolysin production was assessed by halo formation on corresponding agar plates. Only haemolytic activity was observed to varying degrees. Neither protease nor phospholipase was detectable. Biofilm formation on polystyrene surfaces was detected through a formazan salt reduction assay. All clinical isolates had the ability to form biofilm. In contrast to the susceptibility of planktonic T. asahii cells to clinically used amphotericin B, 5-flucytosine, fluconazole, itraconazole and voriconazole, a remarkable rise in the MICs of these for biofilm T. asahii cells was observed. Our results suggested that genotype IV was the most prevalent genotype among T. asahii isolates from ICUs in China. Haemolysin and biofilm might contribute to the pathogenicity and recurrence of T. asahii-related UTIs. Although triazoles, especially voriconazole, were effective against planktonic T. asahii cells, they failed to treat preformed biofilms.
AhmadS.,
KhanZ.,
MokaddasE.,
KhanZ. U.2004; Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait. J Med Microbiol 53:633–637 [View Article][PubMed]
Chagas-NetoT. C.,
ChavesG. M.,
MeloA. S.,
ColomboA. L.2009; Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J Clin Microbiol 47:1074–1081 [View Article][PubMed]
FeraM. T.,
La CameraE.,
De SarroA.2009; New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance. Expert Rev Anti Infect Ther 7:981–998 [View Article][PubMed]
GirmeniaC.,
PaganoL.,
MartinoB.,
D’AntonioD.,
FanciR.,
SpecchiaG.,
MelilloL.,
BuelliM.,
PizzarelliG.other authors2005; Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 43:1818–1828 [View Article][PubMed]
HawserS. P.,
NorrisH.,
JessupC. J.,
GhannoumM. A.1998; Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J Clin Microbiol 36:1450–1452[PubMed]
KauffmanC. A.,
VazquezJ. A.,
SobelJ. D.,
GallisH. A.,
McKinseyD. S.,
KarchmerA. W.,
SugarA. M.,
SharkeyP. K.,
WiseG. J.other authors2000; Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis 30:14–18 [View Article][PubMed]
KumarS.,
BandyopadhyayM.,
MondalS.,
PalN.2011; A rare case of nosocomial urinary tract infection due to Trichosporon asahii
. J Glob Infect Dis 3:309–310 [View Article][PubMed]
MakimuraK.,
MurayamaS. Y.,
YamaguchiH.1994; Detection of a wide range of medically important fungi by the polymerase chain reaction. J Med Microbiol 40:358–364 [View Article][PubMed]
PadhyeA. A.,
HallL.,
RobertsG. D.2002; Deep-seated trichosporonosis in an immunocompetent patient: a case report of uterine trichosporonosis – correction. Clin Infect Dis 35:108–109, author reply 109 [View Article][PubMed]
RastogiV. L.,
NirwanP. S.2007; Invasive trichosporonosis due to Trichosporon asahii in a non-immunocompromised host: a rare case report. Indian J Med Microbiol 25:59–61 [View Article][PubMed]
RichardsM. J.,
EdwardsJ. R.,
CulverD. H.,
GaynesR. P.2000; Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21:510–515 [View Article][PubMed]
Rodriguez-TudelaJ. L.,
Gomez-LopezA.,
Alastruey-IzquierdoA.,
MelladoE.,
Bernal-MartinezL.,
Cuenca-EstrellaM.2007; Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1. Diagn Microbiol Infect Dis 58:435–440 [View Article][PubMed]
SabharwalE. R.2010; Successful management of Trichosporon asahii urinary tract infection with fluconazole in a diabetic patient. Indian J Pathol Microbiol 53:387–388 [View Article][PubMed]
ShinJ. H.,
KeeS. J.,
ShinM. G.,
KimS. H.,
ShinD. H.,
LeeS. K.,
SuhS. P.,
RyangD. W.2002; Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 40:1244–1248 [View Article][PubMed]
SugitaT.,
NakajimaM.,
IkedaR.,
MatsushimaT.,
ShinodaT.2002; Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J Clin Microbiol 40:1826–1830 [View Article][PubMed]
XiaZ.,
YangR.,
WangW.,
CongL.2012; Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients. Mycopathologia 173:127–133 [View Article][PubMed]
Trichosporonasahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing